- News & Analysis
- Home
- Latest News
- Reports
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Job Postings
- Events
Page 259
Spero shoots through series C target
GV has led a consortium that included Osage University Partners in an overubscribed round that closed at $51.7m.
Mar 10, 2017Biohaven closes $80m series A
The Yale spinout has closed an oversubscribed $80m funding round that featured Osage University Partners and Connecticut Innovations, boosting its total funding to $100m.
Mar 8, 2017PMV diagnoses $74m series B
Osage University Partners has taken part in a series B round for PMV Pharmaceuticals.
Mar 1, 2017Therarchon boosts series A to $40m
Bpifrance has joined a consortium of investors that already featured Inserm Transfer Initiative and that previously provided $35m in funding.
Jan 6, 2017Tenaya heartened by $50m series A
A spinout from UCSF affiliate Gladstone Institutes, Tenaya secured funding from VC firm Column Group to develop cures for heart disease.
Dec 7, 2016Investors transplant $48.5m into Magenta series A
Biotechnology developer Magenta Therapeutics, which exploits Harvard research, has launched with series A funding provided by investors including Alphabet.
Nov 17, 2016Emulate expands series B to $45m
The Harvard spinout has increased a round already backed by Cedars-Sinai and LabCorp from $28m to $45m following an extension provided by unnamed new investors.
Oct 24, 2016Oblong enters $65m orbit
Based on research conducted at MIT Media Lab, Oblong Industries is developing spatial, gesture-enabled technologies and has now added Utimco to its shareholders.
Oct 19, 2016About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits our membership, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
We use cookies to enhance your browsing experience and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.


